![Ian McLeod](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian McLeod
Comptroller/Controller/Auditor at
ANIKA THERAPEUTICS, INC.
Net worth: 352 685 $ as of 29/06/2026
Profile
Ian McLeod is currently Chief Accounting Officer, Treasurer & VP at Anika Therapeutics, Inc. since 2021.
Formerly, Mr. McLeod was Controller at ABIOMED, Inc. from 2007 to 2017 and Corporate Controller at Idenix Pharmaceuticals LLC from 2004 to 2007.
Mr. McLeod completed undergraduate studies at the University of Western Ontario and earned an MBA from McMaster University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 24,107 ( 0.18% ) | 352 685 $ | 29/06/2026 |
Ian McLeod active positions
| Companies | Position | Start |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/06/2021 |
Former positions of Ian McLeod
| Companies | Position | End |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 31/10/2007 |
| ABIOMED, INC. | Comptroller/Controller/Auditor | - |
Training of Ian McLeod
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Ian McLeod
